Imunon Net Income Over Time
| IMNN Stock | USD 3.27 0.15 4.39% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Imunon Performance and Imunon Correlation. Will Biotechnology sector continue expanding? Could Imunon diversify its offerings? Factors like these will boost the valuation of Imunon. Market participants price Imunon higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Imunon data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding Imunon Inc requires distinguishing between market price and book value, where the latter reflects Imunon's accounting equity. The concept of intrinsic value - what Imunon's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Imunon's price substantially above or below its fundamental value.
Please note, there is a significant difference between Imunon's value and its price as these two are different measures arrived at by different means. Investors typically determine if Imunon is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Imunon's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Cross Equities Net Income Analysis
Compare Imunon Inc and related stocks such as Sensei Biotherapeutics, Dogwood Therapeutics, and Bolt Biotherapeutics Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SNSE | (13 M) | (13 M) | (13 M) | (13 M) | (13 M) | (13 M) | (13 M) | (13 M) | (13 M) | (16.7 M) | (20.1 M) | (36.8 M) | (48.8 M) | (34.1 M) | (30.2 M) | (27.1 M) | (28.5 M) |
| DWTX | (2.1 M) | (2.1 M) | (2.1 M) | (2.1 M) | (2.1 M) | (2.1 M) | (2.1 M) | (2.1 M) | (2.1 M) | (2.5 M) | (10.3 M) | (16 M) | (12.2 M) | (5.3 M) | (12.3 M) | (11.1 M) | (11.7 M) |
| BOLT | (11.6 M) | (11.6 M) | (11.6 M) | (11.6 M) | (11.6 M) | (11.6 M) | (11.6 M) | (11.6 M) | (11.6 M) | (30.5 M) | (60.7 M) | (98.6 M) | (88.1 M) | (69.2 M) | (63.1 M) | (56.8 M) | (59.6 M) |
| EVGN | 645 K | 645 K | (2.5 M) | (8.9 M) | (14.5 M) | (17.2 M) | (19.6 M) | (20.8 M) | (20.8 M) | (18.1 M) | (23.4 M) | (27.8 M) | (26.6 M) | (23.9 M) | (16.5 M) | (14.8 M) | (15.6 M) |
| CLRB | (815.3 K) | (7.4 M) | (8.8 M) | (10.8 M) | (8.1 M) | (5.5 M) | (6.2 M) | (13.6 M) | (13.2 M) | (14.1 M) | (15.1 M) | (24 M) | (28.6 M) | (42.8 M) | (44.6 M) | (40.1 M) | (38.1 M) |
| COCP | (58.7 K) | (5.5 M) | (8 M) | (19.6 M) | (99 K) | (50.1 M) | (74.9 M) | (613 K) | (49 M) | (48.2 M) | (9.6 M) | (14.2 M) | (38.8 M) | (18 M) | (17.5 M) | (15.8 M) | (16.5 M) |
| AEON | 172.9 M | 172.9 M | 172.9 M | 172.9 M | 172.9 M | 172.9 M | 172.9 M | 172.9 M | 172.9 M | 172.9 M | (32.9 M) | (55.6 M) | (52.6 M) | (384.6 M) | 42 M | 37.8 M | 39.7 M |
| CING | (11.5 M) | (11.5 M) | (11.5 M) | (11.5 M) | (11.5 M) | (11.5 M) | (11.5 M) | (11.5 M) | (11.5 M) | (11.5 M) | (7.2 M) | (20.7 M) | (17.9 M) | (23.5 M) | (15.5 M) | (14 M) | (14.7 M) |
| MRKR | (1.1 M) | (2 M) | (5.9 M) | (5.5 M) | (30.9 M) | (34.1 M) | (2.5 M) | (11 M) | (148 M) | (21.4 M) | (28.7 M) | (41.9 M) | (29.9 M) | (8.2 M) | (10.7 M) | (9.7 M) | (10.1 M) |
| TRAW | (30.3 M) | (30.3 M) | (33.9 M) | (64.9 M) | (63.7 M) | (24 M) | (19.7 M) | (24.1 M) | (20.6 M) | (21.5 M) | (25.2 M) | (16.2 M) | (19 M) | (18.9 M) | (54.7 M) | (62.9 M) | (66 M) |
Imunon Inc and related stocks such as Sensei Biotherapeutics, Dogwood Therapeutics, and Bolt Biotherapeutics Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Imunon Inc financial statement analysis. It represents the amount of money remaining after all of Imunon Inc operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Imunon Inc | IMNN |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 997 Lenox Drive, |
| Exchange | NASDAQ Exchange |
USD 3.27
Check out Imunon Performance and Imunon Correlation. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Imunon technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.